{"transactions":[{"id":747788,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T21:00:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259855/ownership.xml","form_type":"4"}},{"id":1117771,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083702/ownership.xml","form_type":"4"}},{"id":1171725,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-15T21:30:04.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":757,"price":9.8481,"value":7455.0117,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.56 to $10.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":18347,"source":{"system":"sec-edgar","filing":"0000950170-25-054331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025054331/ownership.xml","form_type":"4"}},{"id":1497760,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:15:04.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066605/ownership.xml","form_type":"4"}},{"id":1501824,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T20:10:10.000Z","date":"2024-05-23","kind":"sale","planned":false,"acquired":false,"shares":2117,"price":14.9338,"value":31614.8546,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":19104,"source":{"system":"sec-edgar","filing":"0000950170-24-064586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024064586/ownership.xml","form_type":"4"}},{"id":1553306,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:25:20.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":1206,"price":13.0719,"value":15764.7114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9."}],"balance_after":21221,"source":{"system":"sec-edgar","filing":"0000950170-24-040205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040205/ownership.xml","form_type":"4"}},{"id":1874685,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:35:08.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2024 and (2) the date of the Issuer's 2024 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":0.972,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-032900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123032900/doc4.xml","form_type":"4"}},{"id":1879614,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T21:15:26.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":25972,"price":1.0403,"value":27018.6716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":169160,"source":{"system":"sec-edgar","filing":"0001209191-23-031919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123031919/doc4.xml","form_type":"4"}},{"id":1879613,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T21:15:26.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":117500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated July 22, 2021. On May 22, 2023, the performance-based vesting conditions were achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: May 22, 2023 and May 22, 2024."}],"balance_after":295132,"source":{"system":"sec-edgar","filing":"0001209191-23-031919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123031919/doc4.xml","form_type":"4"}},{"id":1933875,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T20:45:15.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":14883,"price":0.8232,"value":12251.6856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7795 to $0.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":177632,"source":{"system":"sec-edgar","filing":"0001209191-23-021886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123021886/doc4.xml","form_type":"4"}},{"id":2165001,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-06T19:25:15.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day immediately prior to the date of the Issuer's 2023 annual meeting of stockholders."}],"balance_after":16500,"derivative":{"exercise_price":0.42,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-048886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1634379/000120919122048886/doc4.xml","form_type":"4"}},{"id":2189299,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-10T21:00:23.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":12314,"price":2.1277,"value":26200.4978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":192515,"source":{"system":"sec-edgar","filing":"0001209191-22-045239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122045239/doc4.xml","form_type":"4"}},{"id":2312835,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Performance-based Restricted Stock Units","published_at":"2022-03-31T20:36:52.000Z","date":"2022-03-29","kind":"grant","acquired":true,"shares":83750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance-based restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The shares are earned if either of two trading price metrics are met (each a \"Stock Metric\") either on or before the second or on or before the fourth anniversary of the grant date, as applicable. If a Stock Metric is met on or before the first anniversary of the grant date, then 50% of the RSUs vest on the first anniversary of the grant date and the remainder will vest on the second anniversary of the grant date. If a Stock Metric is achieved after the first anniversary of the grant date and on or before the fourth anniversary of the grant date, then 50% of the RSUs vest on the date that the Stock Metric is achieved and the remaining 50% of the RSUs vest on the first anniversary of the initial vesting date. Special vesting provisions apply in the case of a change in control transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each performance-based restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The shares are earned if either of two trading price metrics are met (each a \"Stock Metric\") either on or before the second or on or before the fourth anniversary of the grant date, as applicable. If a Stock Metric is met on or before the first anniversary of the grant date, then 50% of the RSUs vest on the first anniversary of the grant date and the remainder will vest on the second anniversary of the grant date. If a Stock Metric is achieved after the first anniversary of the grant date and on or before the fourth anniversary of the grant date, then 50% of the RSUs vest on the date that the Stock Metric is achieved and the remaining 50% of the RSUs vest on the first anniversary of the initial vesting date. Special vesting provisions apply in the case of a change in control transaction."}],"balance_after":83750,"derivative":{"expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":83750},"source":{"system":"sec-edgar","filing":"0001209191-22-021770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122021770/doc4.xml","form_type":"4"}},{"id":2312834,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-31T20:36:52.000Z","date":"2022-03-29","kind":"grant","acquired":true,"shares":335000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2023; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2026."}],"balance_after":335000,"derivative":{"exercise_price":2.3,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":335000},"source":{"system":"sec-edgar","filing":"0001209191-22-021770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122021770/doc4.xml","form_type":"4"}},{"id":2312833,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-03-31T20:36:52.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":4614,"price":2.1674,"value":10000.3836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":204829,"source":{"system":"sec-edgar","filing":"0001209191-22-021770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122021770/doc4.xml","form_type":"4"}},{"id":2312832,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-03-31T20:36:52.000Z","date":"2022-03-29","kind":"grant","acquired":true,"shares":83750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2023; March 29, 2024; March 29, 2025; and March 29, 2026."}],"balance_after":209443,"source":{"system":"sec-edgar","filing":"0001209191-22-021770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919122021770/doc4.xml","form_type":"4"}},{"id":2608379,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-08-10T21:09:27.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":12156,"price":3.6016,"value":43781.0496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":125693,"source":{"system":"sec-edgar","filing":"0001209191-21-050645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919121050645/doc4.xml","form_type":"4"}},{"id":2696516,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-25T18:54:52.000Z","date":"2021-05-24","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day immediately prior to the date of the Issuer's 2022 annual meeting of stockholders."}],"balance_after":16500,"derivative":{"exercise_price":4.07,"expiration_date":"2031-05-23","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-21-035772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1634379/000120919121035772/doc4.xml","form_type":"4"}},{"id":2760998,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-02T20:35:27.000Z","date":"2021-03-29","kind":"grant","acquired":true,"shares":305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2022; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2025."}],"balance_after":305000,"derivative":{"exercise_price":4.33,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":305000},"source":{"system":"sec-edgar","filing":"0001209191-21-024621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919121024621/doc4.xml","form_type":"4"}},{"id":3063343,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-08-10T20:34:45.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":756,"price":22.4995,"value":17009.622,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.39 to $22.62, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":137849,"source":{"system":"sec-edgar","filing":"0001209191-20-045952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/doc4.xml","form_type":"4"}},{"id":3063342,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-08-10T20:34:45.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":11395,"price":21.7558,"value":247907.341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.38 to $22.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":138605,"source":{"system":"sec-edgar","filing":"0001209191-20-045952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/doc4.xml","form_type":"4"}},{"id":3190782,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-31T20:12:52.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on March 29, 2021; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2024."}],"balance_after":100000,"derivative":{"exercise_price":14.45,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-021796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/doc4.xml","form_type":"4"}},{"id":3190781,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-03-31T20:12:52.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2021; March 29, 2022; March 29, 2023; and March 29, 2024."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-20-021796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/doc4.xml","form_type":"4"}},{"id":3402910,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Performance-based Restricted Stock Units","published_at":"2019-10-01T22:05:34.000Z","date":"2019-09-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Assembly Biosciences, Inc. common stock. The shares of common stock are earned if market-based performance metrics are met (the \"Milestone\") on or before the third anniversary of the grant date. If the Milestone is achieved on or before the second anniversary of the grant date, then the RSUs shall become fully vested on the second anniversary of the grant date. If the Milestone is achieved after the second anniversary of the grant date and on or before the third anniversary of the grant date, then the RSUs shall become fully vested on the third anniversary of the grant date. Any RSU that has not been earned and vested as of the third anniversary of the grant will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance-based Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Assembly Biosciences, Inc. common stock. The shares of common stock are earned if market-based performance metrics are met (the \"Milestone\") on or before the third anniversary of the grant date. If the Milestone is achieved on or before the second anniversary of the grant date, then the RSUs shall become fully vested on the second anniversary of the grant date. If the Milestone is achieved after the second anniversary of the grant date and on or before the third anniversary of the grant date, then the RSUs shall become fully vested on the third anniversary of the grant date. Any RSU that has not been earned and vested as of the third anniversary of the grant will be forfeited."}],"balance_after":25000,"derivative":{"expiration_date":"2022-09-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-051355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919119051355/doc4.xml","form_type":"4"}},{"id":3443452,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-08T22:10:11.000Z","date":"2019-08-06","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over three years, assuming continuous service on each vesting date, as follows: one-third will vest on the first anniversary of the date of grant, August 6, 2020; and the remaining two-thirds will vest in 24 approximately equal monthly installments, with the options becoming fully vested on August 6, 2022."}],"balance_after":500000,"derivative":{"exercise_price":11.86,"expiration_date":"2029-08-06","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001144204-19-038644","document":"tv527181_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/tv527181_4.xml","form_type":"4"}},{"id":3443451,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-08T22:10:11.000Z","date":"2019-08-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in three approximately equal installments, assuming continuous service on each vesting date, as follows: August 6, 2020; August 6, 2021; and August 6, 2022."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001144204-19-038644","document":"tv527181_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/tv527181_4.xml","form_type":"4"}},{"id":408164,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Restricted Stock Unit","published_at":"2019-02-09T00:55:35.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":14550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":16015,"derivative":{"underlying":"Common Stock","underlying_shares":14550},"source":{"system":"sec-edgar","filing":"0001127602-19-004925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004925/form4.xml","form_type":"4"}},{"id":408163,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-02-09T00:55:35.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":67310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":67310,"derivative":{"exercise_price":68.75,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":67310},"source":{"system":"sec-edgar","filing":"0001127602-19-004925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004925/form4.xml","form_type":"4"}},{"id":408162,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2019-02-09T00:55:35.000Z","date":"2019-02-06","kind":"tax_withholding","acquired":false,"shares":4453,"price":68.75,"value":306143.75,"ownership":{"direct":true},"balance_after":37828,"source":{"system":"sec-edgar","filing":"0001127602-19-004925","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004925/form4.xml","form_type":"4"}},{"id":408161,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2019-02-09T00:55:35.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":7104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":42281,"source":{"system":"sec-edgar","filing":"0001127602-19-004925","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004925/form4.xml","form_type":"4"}},{"id":408160,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2019-02-09T00:55:35.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":8323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 16, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":35177,"source":{"system":"sec-edgar","filing":"0001127602-19-004925","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004925/form4.xml","form_type":"4"}},{"id":409762,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2018-12-19T19:33:54.000Z","date":"2018-12-17","kind":"tax_withholding","acquired":false,"shares":2988,"price":65.12,"value":194578.56,"ownership":{"direct":true},"balance_after":26854,"source":{"system":"sec-edgar","filing":"0001127602-18-036847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218036847/form4.xml","form_type":"4"}},{"id":409761,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2018-12-19T19:33:54.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":6135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Issuance of common stock upon vesting of certain performance share awards on December 17, 2018."}],"balance_after":29842,"source":{"system":"sec-edgar","filing":"0001127602-18-036847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218036847/form4.xml","form_type":"4"}},{"id":410720,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Restricted Stock Unit","published_at":"2018-11-13T21:57:34.000Z","date":"2018-11-10","kind":"exercise","acquired":false,"shares":1465,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":1465,"derivative":{"underlying":"Common Stock","underlying_shares":1465},"source":{"system":"sec-edgar","filing":"0001127602-18-032917","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032917/form4.xml","form_type":"4"}},{"id":410719,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2018-11-13T21:57:34.000Z","date":"2018-11-10","kind":"tax_withholding","acquired":false,"shares":664,"price":71.18,"value":47263.52,"ownership":{"direct":true},"balance_after":23707,"source":{"system":"sec-edgar","filing":"0001127602-18-032917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032917/form4.xml","form_type":"4"}},{"id":410718,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Common Stock","published_at":"2018-11-13T21:57:34.000Z","date":"2018-11-10","kind":"exercise","acquired":true,"shares":1465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":24371,"source":{"system":"sec-edgar","filing":"0001127602-18-032917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032917/form4.xml","form_type":"4"}},{"id":415059,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"officer":true,"officer_title":"Chief Scientific Off/HeadR&D"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-05-10T21:21:00.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":79710,"price":65.22,"value":5198686.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested"}],"balance_after":79710,"derivative":{"exercise_price":65.22,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":79710},"source":{"system":"sec-edgar","filing":"0001127602-18-017110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218017110/form4.xml","form_type":"4"}}]}